Blue-Gray Nails and Skin

Robert L. Gauer, MD
Daniel Blankinship, DO

American Family Physician. 2026;113(5):495-496.

Author disclosure: No relevant financial relationships.

A 74-year-old woman presented with changes in the color of her nails and skin that started 15 years earlier. She had a history of type 2 diabetes, obstructive sleep apnea, recent lower extremity deep venous thrombosis treated with apixaban (Eliquis), and endometrial cancer. She consumed a daily colloidal silver supplement (6 oz) for viral illnesses and minor skin infections. She lived on a farm and used well water.

Physical examination revealed blue-gray discoloration of her nail lunulae and skin (Figure 1 and Figure 2). There was no evidence of cyanosis. Iron studies and measurement of arterial blood gases, ceruloplasmin, and urinary copper levels had normal results.

FIGURE 1

FIGURE 2

QUESTION

Based on the patient’s history and physical examination, which one of the following is the most likely diagnosis?

A. Alkaptonuria.

B. Argyria.

C. Hemochromatosis.

D. Methemoglobinemia.

E. Wilson disease.

DISCUSSION

The answer is B: argyria, discoloration of tissues and organs caused by chronic absorption of products that contain silver. Silver deposition typically occurs in the skin and can manifest as localized dark-blue macules to a generalized gray-blue skin tone. The discoloration is most prominent in sun-exposed areas.1 Localized cutaneous argyria can occur when silver makes direct contact with an area of skin on a regular basis, as seen in occupational exposures. This is most common in silversmiths or welders but may also result from repeated or prolonged contact with acupuncture needles, jewelry, or topical medications such as silver nitrate.2 When silver intake exceeds the excretory capabilities of the liver and kidneys, the excess metal is deposited in the tissues and can lead to generalized argyria. This can occur in virtually every organ, including the skin.3

Despite the lack of evidence of effectiveness, silver is sometimes believed to be a cure-all in alternative and homeopathic medicine.4

Argyria is a benign condition, although it can be cosmetically distressing. Treatment options are limited because the skin changes are often permanent. Treatment with hydroquinone, oral penicillamine, or dermabrasion is not effective. Success has been reported with laser techniques.5

Alkaptonuria is a rare genetic disorder in which an enzyme deficiency results in accumulation of homogentisic acid in connective tissue. Over time, collagenous tissues darken, resulting in a blue-gray pigmentation (ochronosis). Ochronosis most often develops in patients 30 to 60 years of age and commonly affects large joints, kidneys, the cardiovascular system, skin, and glands. Arthropathy is a distinct clinical feature.6

Hemochromatosis is caused by excessive iron accumulation in body tissues and leads to multiorgan dysfunction. This often results in liver disease, heart failure, diabetes, and skin discoloration.7 The discoloration is classically a bronze tone, but blue-gray discoloration is possible. Patients have markedly elevated ferritin and transferrin saturation levels.

Methemoglobinemia is a rare disorder that can be congenital or acquired. It is associated with oxidation of heme iron to its ferric state, which results in impaired oxygen release to tissues and hypoxia. The blue-gray skin discoloration in methemoglobinemia is a result of cyanosis. More severe manifestations can include seizures, dysrhythmias, and central nervous system depression. Acquired causes are generally due to medications.8

ROBERT L. GAUER, MD, and DANIEL BLANKINSHIP, DO, Womack Army Medical Center, Fort Bragg, North Carolina

Address correspondence to Robert L. Gauer, MD, at robertgauer@yahoo.com.

Author disclosure: No relevant financial relationships.

  1. 1.Mota L, Dinis-Oliveira RJ. Clinical and forensic aspects of the different subtypes of argyria. J Clin Med. 2021;10(10):2086.
  2. 2.Beutler BD, Lee RA, Cohen PR. Localized cutaneous argyria: report of two patients and literature review. Dermatol Online J. 2016;22(11):13030/qt4wm1j7pt.
  3. 3.Lencastre A, Lobo M, João A. Argyria – case report. An Bras Dermatol. 2013;88(3):413-416.
  4. 4.Park SW, Shin HT, Lee KT, et al. Medical concern for colloidal silver supplementation: argyria of the nail and face. Ann Dermatol. 2013;25(1):111-112.
  5. 5.Molina-Hernandez AI, Diaz-Gonzalez JM, Saeb-Lima M, et al. Argyria after silver nitrate intake: case report and brief review of literature. Indian J Dermatol. 2015;60(5):520.
  6. 6.Mistry JB, Bukhari M, Taylor AM. Alkaptonuria. Rare Dis. 2013;1:e27475.
  7. 7.Girelli D, Busti F, Brissot P, et al. Hemochromatosis classification: update and recommendations by the BIOIRON Society. Blood. 2022;139(20):3018-3029.
  8. 8.Iolascon A, Bianchi P, Andolfo I, et al.; SWG of red cell and iron of EHA and EuroBloodNet. Recommendations for diagnosis and treatment of methemoglobinemia. Am J Hematol. 2021;96(12):1666-1678.
  9. 9.Schilsky ML, Roberts EA, Bronstein JM, et al. A multidisciplinary approach to the diagnosis and management of Wilson disease: 2022 practice guidance on Wilson disease from the American Association for the Study of Liver Diseases. Hepatology. 2025;82(3):E41-E90.

The editors of AFP welcome submissions for Photo Quiz. Guidelines for preparing and submitting a Photo Quiz manuscript can be found in the Authors' Guide at https://www.aafp.org/afp/photoquizinfo. To be considered for publication, submissions must meet these guidelines. Email submissions to afpphoto@aafp.org.

This series is coordinated by John E. Delzell Jr., MD, MSPH, associate medical editor.

A collection of Photo Quiz published in AFP is available at https://www.aafp.org/afp/photoquiz.

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.